We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCC
426
WESCO International
WCC
$18B
$507K 0.01%
+2,830
New +$413K
ADBE icon
427
Adobe
ADBE
$106B
$505K 0.01%
1,033
-8,967
-90% -$3.61M
CTRE icon
428
CareTrust REIT
CTRE
$9.66B
$502K 0.01%
+25,270
New +$494K
ASAN icon
429
Asana
ASAN
$2.14B
$474K 0.01%
21,510
-203,490
-90% -$4.08M
PEN icon
430
Penumbra
PEN
$12.8B
$471K 0.01%
1,369
-1,073
-44% -$329K
UBX
431
DELISTED
Unity Biotechnology
UBX
$457K 0.01%
179,080
-33,960
-16% -$89.7K
SPY icon
432
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$456K 0.01%
449,000
+54,000
+14% +$22.7M
CPRI icon
433
PUT
Capri Holdings
CPRI
$1.71B
$452K 0.01%
18,200
– –
F icon
434
PUT
Ford
F
$55.3B
$450K 0.01%
740,900
-30,300
-4% -$383K
CTMX icon
435
CytomX Therapeutics
CTMX
$745M
$447K 0.01%
259,965
+12,808
+5% +$21.3K
CYPH
436
Cypherpunk Technologies Inc
CYPH
$76.1M
$436K 0.01%
139,434
+34,565
+33% +$174K
OVID icon
437
Ovid Therapeutics
OVID
$491M
$426K 0.01%
+130,000
New +$441K
SPLK
438
DELISTED
Splunk Inc
SPLK
$424K 0.01%
+4,000
New +$380K
GPCR icon
439
Structure Therapeutics
GPCR
$3.7B
$424K 0.01%
10,193
-11,857
-54% -$332K
M icon
440
PUT
Macy's
M
$6.53B
$419K 0.01%
112,500
– –
LCID icon
441
Lucid Motors
LCID
$2.76B
$413K 0.01%
+6,000
New +$428K
ESPR
442
DELISTED
Esperion Therapeutics
ESPR
$413K 0.01%
296,947
+90,688
+44% +$127K
ABOS icon
443
Acumen Pharmaceuticals
ABOS
$167M
$383K 0.01%
79,538
+18,180
+30% +$87K
SAVE
444
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$382K 0.01%
250,000
+150,000
+150% +$2.46M
ORTX
445
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$369K 0.01%
71,010
+3,498
+5% +$17.8K
SPT icon
446
Sprout Social
SPT
$621M
$346K 0.01%
7,500
-22,500
-75% -$1.07M
QURE icon
447
PUT
uniQure
QURE
$3.2B
$338K 0.01%
+55,000
New +$1.04M
RNG icon
448
RingCentral
RNG
$5.37B
$332K 0.01%
10,155
-22,500
-69% -$691K
PRQR icon
449
ProQR Therapeutics
PRQR
$272M
$307K 0.01%
189,328
+9,328
+5% +$18.2K
PLTR icon
450
Palantir
PLTR
$410B
$303K 0.01%
+19,773
New +$225K
16 17
18
19 20

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.